Autoimmune drug pipeline: What health execs should watchNew drugs for RA, psoriasis, type 1 diabetes and Crohn’s disease—some recently approved and others coming down the pipeline—could have an impact on the industry.
Biosimilar drugs appear comparable to brand-name counterpartsSystematic review provides comprehensive first look at TNF-alpha biosimilar treatments.
FDA approves Cimzia for psoriatic arthritisCimzia (certolizumab pegol, UCB) has been approved by the Food and Drug Administration for the treatment of psoriatic arthritis in adult patients.